Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Biogen Pharmachem Industries Ltd (531752)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531752 NSE: Trading | Small Cap | Biogen Pharmachem Share Price
₹0.28 0.00 (0.00%)
As on 25-Sep'26 12:03
Biogen Pharmachem Industries Ltd (531752)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531752 NSE: Trading | Small Cap | Biogen Pharmachem Share Price
₹0.28 0.00 (0.00%)
As on 25-Sep'26 12:03
Key Metrics
Valuation Multiples
Market Cap
₹29 Cr.
Current Price
₹0.3
52-Week Low / High
₹0 / 1
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
39.4
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
0.00%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹105.3 Cr.
Face Value
₹1
All Time Low / High
₹0.01 / 16.03
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Biogen Pharmachem Industries Ltd a good quality company?
Biogen Pharmachem Industries Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Biogen Pharmachem Industries Ltd performance compare with that of its Peers?
Revenue growth of Biogen Pharmachem Industries Ltd vs industry peers?
Biogen Pharmachem Industries Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Biogen Pharmachem Industries Ltd?
Promoters hold 0.00% of the Biogen Pharmachem Industries Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Biogen Pharmachem Industries Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 4.5% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Biogen Pharmachem Industries Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -0% | -0.2% | -11.3% | -0% | -0.2% | -2.9% | -0% | 0.8% | 3.5% | -0.4% | - |
| Value Creation Index ⓘ | -1.0 | -1.0 | -1.8 | -1.0 | -1.0 | -1.2 | -1.0 | -0.9 | -0.8 | -1.0 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 0 | 1 | 0 | 1.6 | 2.5 | 0 | 0 | 0 | 0 |
| Sales YoY Gr. | - | NA | NA | NA | -100% | NA | 52.5% | -100% | NA | NA | - |
| Adj EPS ⓘ | -0 | -0 | -0 | 0 | -0 | -0 | 0 | -0 | 0 | -0 | 0 |
| YoY Gr. | - | NA | NA | NA | NA | NA | NA | NA | NA | -100% | - |
| BVPS (₹) ⓘ | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 1.1 |
| Adj Net Profit ⓘ | -0 | -0.1 | -1.9 | -0 | -0.1 | -0.5 | 0.2 | -0 | 0.8 | -0 | 0 |
| Cash Flow from Ops. ⓘ | 4.7 | -0.1 | -13.7 | 0.1 | -1.2 | 4 | 1.4 | 1.7 | 1.9 | -1.1 | - |
| Debt/CF from Ops. ⓘ | 1.3 | -10.8 | -0 | 7.2 | -0.3 | 0 | 0 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | -100% | NA | ||||
| Adj EPS ⓘ | NA | NA | NA | -100% | ||||
| BVPSⓘ | -0.9% | 0.3% | 1.4% | 0% | ||||
| Share Price | 4.5% | -12% | -26% | -62.2% | ||||
Key Financial Parameters ⓘ
| Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -0.1 | -0.2 | -3.3 | -0 | -0.2 | -0.9 | 0.4 | -0 | 1.5 | -0.1 | 0 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | -0.4 | 0 | 0.3 | 12 | 0 | 0 | 0 | NAN |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | -0.4 | 0 | -29.4 | 8.5 | 0 | 0 | 0 | NAN |
| Debt to Equity ⓘ | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 19,937 | 0 | 10,617 | 6,835 | 0 | 0 | 0 | 0 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 2,683 | 0 | 1,181 | 182 | 0 | 0 | 0 | 0 |
Valuation of Biogen Pharmachem - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Biogen Pharmachem Industries Ltd FAQs
The current trading price of Biogen Pharmachem on 25-Sep-2026 12:03 is ₹0.28.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Biogen Pharmachem stood at ₹29.49 Cr
The latest P/E ratio of Biogen Pharmachem as of 24-Sep-2026 is 0.00.
The latest P/B ratio of Biogen Pharmachem as of 24-Sep-2026 is 0.26.
The 52-week high of Biogen Pharmachem is ₹0.77 and the 52-week low is ₹0.25.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biogen Pharmachem is ₹0.00 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biogen Pharmachem Industries Ltd is a below average quality company.
The key valuation ratios of Biogen Pharmachem Industries Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biogen Pharmachem Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Biogen Pharmachem Industries Ltd
Sun Techno Overseas Ltd., formerly Wellworth Overseas Limited, is an India-based company.In 2011 the company changed its name from Wellworth Overseas Ltd. to Sun Techno Overseas Ltd.
The company is engaged in the business of trading in shares and securities, small level of stock broking and consulting works. As of March 31, 2009, the company had started trading operations and business in commodities, both in agro-based and precious metals, and other goods in present and future markets.
The company is also diversifying its business activities in the power sector, by establishing wind power generation plant.
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
